title: The science, economics, and effectiveness of combination therapy for hepatitis C.
authors.affiliation: Royal Free and University College School of Medicine, Hampstead, London, UK.
authors.forename: G
authors.initials: G
authors.lastname: Dusheiko
authors.forename: E
authors.initials: E
authors.lastname: Barnes
authors.forename: G
authors.initials: G
authors.lastname: Webster
authors.forename: S
authors.initials: S
authors.lastname: Whalley
mesh_terms: D000998:Antiviral Agents / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D004359:Drug Therapy, Combination; D006526:Hepatitis C / Q000188:drug therapy* / Q000191:economics; D006801:Humans; D012254:Ribavirin / Q000191:economics / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin